R. Wootton

发表

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

P. Rolan, J. Posner, J. Soul-Lawton, 1995, Antimicrobial agents and chemotherapy.

THE INTERACTION OF HUMAN HAEMOGLOBIN WITH ALLOSTERIC EFFECTORS AS A MODEL FOR DRUG‐RECEPTOR INTERACTIONS

P. Goodford, R. Wootton, J. St-Louis, 1980, British journal of pharmacology.

Phase I study of BW12C in combination with mitomycin C in patients with advanced gastrointestinal cancer.

N. Bleehen, P. Workman, J. Ramsay, 1992, International journal of radiation oncology, biology, physics.

Interactive television and the NHS: too much television could be bad for your health

R. Wootton, P. McLaren, 1998, Journal of the Royal Society of Medicine.

Comparison of the pharmacokinetics of lamotrigine in patients with chronic renal failure and healthy volunteers.

P. Rolan, J. Posner, J. Soul-Lawton, 1997, British journal of clinical pharmacology.

Pharmacokinetics and pharmacodynamics of tucaresol, an antisickling agent, in healthy volunteers.

P. Rolan, J. Posner, R. Wootton, 1995, British journal of clinical pharmacology.

High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells.

A. Newman-Tancredi, P. Strange, R. Wootton, 1992, The Biochemical journal.

The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agent.

J. Posner, R. Wootton, S. Jackson, 1995, British journal of clinical pharmacology.

Glycyl-L-proline transport in rabbit enterocyte basolateral-membrane vesicles.

S. Shirazi-Beechey, J. Gorvel, J. Dyer, 1990, The Biochemical journal.

Inhibition of dihydropyrimidine dehydrogenase by 5‐propynyluracil, a metabolite of the anti‐varicella zoster virus agent netivudine

P. Crome, J. Posner, L. Frick, 1996, Clinical pharmacology and therapeutics.

Effect of food and gender on the pharmacokinetics of tucaresol in healthy volunteers.

G. Layton, J. Posner, R. Wootton, 1998, British journal of clinical pharmacology.

The effect of 2,3‐diphosphoglycerate on the oxygen dissociation curve of human haemoglobin.

P. Goodford, R. Wootton, F. Norrington, 1977, The Journal of physiology.

Nuclear quadrupole resonance spectra of pyridine N-oxide complexes of copper(II) halides

R. Wootton, J. J. R. F. Silva, 1971 .

Preparation of N-salicylideneamino-acid and -ester complexes of oxovanadium-(IV) and -(V)

R. Gillard, R. Wootton, J. J. R. F. Silva, 1970 .

Physiochemical-activity relations in practice. 1. A rational and self-consistent data bank.

R. M. Hyde, R. Wootton, F E Norrington, 1975, Journal of medicinal chemistry.

Complexes of copper(II) with the ephedrines

R. Gillard, R. Wootton, 1971 .

A quantitative analysis of the effects of 2,3‐diphosphoglycerate, adenosine triphosphate and inositol hexaphosphate on the oxygen dissociation curve of human haemoglobin.

P. Goodford, R. Wootton, J. St-Louis, 1978, The Journal of physiology.

Analysis of the effect of bezafibrate on the oxygen dissociation curve of human hemoglobin

R. Wootton, 1984, FEBS letters.

Substituted benzaldehydes designed to increase the oxygen affinity of human haemoglobin and inhibit the sickling of sickle erythrocytes

C. Beddell, P. Goodford, R. Wootton, 1984, British journal of pharmacology.

COMPOUNDS DESIGNED TO FIT A SITE OF KNOWN STRUCTURE IN HUMAN HAEMOGLOBIN

P J Goodford, C. Beddell, P. Goodford, 1976, British journal of pharmacology.

The pharmacokinetics, tolerability and pharmacodynamics of tucaresol (589C80; 4[2-formyl-3-hydroxyphenoxymethyl] benzoic acid), a potential anti-sickling agent, following oral administration to healthy subjects.

B. Weatherley, P. Rolan, J. Posner, 1993, British journal of clinical pharmacology.

Characterization of the binding of the anti-sickling compound, BW12C, to haemoglobin.

D. Stammers, M. Merrett, R. Wootton, 1986, The Biochemical journal.

The effects in volunteers of BW12C, a compound designed to left-shift the blood-oxygen saturation curve.

B. Weatherley, R. Wootton, A. Mclean, 1985, British journal of clinical pharmacology.

Pharmacokinetics and tolerability of single oral doses of 882C87, a potent, new anti-varicella-zoster virus agent, in healthy volunteers

B. Weatherley, P. Crome, J. Posner, 1995, Antimicrobial agents and chemotherapy.

SPECIES DIFFERENCES IN THE BINDING OF COMPOUNDS DESIGNED TO FIT A SITE OF KNOWN STRUCTURE IN ADULT HUMAN HAEMOGLOBIN

P J Goodford, C. Beddell, D. Stammers, 1979, British journal of pharmacology.

Physicochemical-activity relationship in practice. 2. Rational selection of benzenoid substituents.

P J Goodford, P. Goodford, R. Wootton, 1975, Journal of medicinal chemistry.

Physiotherapy in treatment of burns with inhalation involvement.

R. Wootton, E. Hodgson, 1977, Physiotherapy.

Reactions of some copper(II) complexes of the Schiff bases of amino-acid esters

R. Gillard, R. Wootton, 1970 .

Reduction in potency and reversal of left‐shifting activity of BW12C with the major and minor components of chicken hemoglobin

D. Stammers, R. Wootton, R. D. White, 1986, FEBS letters.